Modulation of metal-azolate frameworks for the tunable release of encapsulated glycosaminoglycans.
Journal
Chemical science
ISSN: 2041-6520
Titre abrégé: Chem Sci
Pays: England
ID NLM: 101545951
Informations de publication
Date de publication:
14 Jul 2020
14 Jul 2020
Historique:
entrez:
7
6
2021
pubmed:
8
6
2021
medline:
8
6
2021
Statut:
epublish
Résumé
Glycosaminoglycans (GAGs) are biomacromolecules necessary for the regulation of different biological functions. In medicine, GAGs are important commercial therapeutics widely used for the treatment of thrombosis, inflammation, osteoarthritis and wound healing. However, protocols for the encapsulation of GAGs in MOFs carriers are not yet available. Here, we successfully encapsulated GAG-based clinical drugs (heparin, hyaluronic acid, chondroitin sulfate, dermatan sulfate) and two new biotherapeutics in preclinical stage (GM-1111 and HepSYL proteoglycan) in three different pH-responsive metal-azolate frameworks (ZIF-8, ZIF-90, and MAF-7). The resultant GAG@MOF biocomposites present significant differences in terms of crystallinity, particle size, and spatial distribution of the cargo, which influences the drug-release kinetics upon applying an acidic stimulus. For a selected system, heparin@MOF, the released therapeutic retained its antithrombotic activity while the MOF shell effectively protects the drug from heparin lyase. By using different MOF shells, the present approach enables the preparation of GAG-based biocomposites with tunable properties such as encapsulation efficiency, protection and release.
Identifiants
pubmed: 34094337
doi: 10.1039/d0sc01204a
pii: d0sc01204a
pmc: PMC8162298
doi:
Types de publication
Journal Article
Langues
eng
Pagination
10835-10843Informations de copyright
This journal is © The Royal Society of Chemistry.
Déclaration de conflit d'intérêts
There are no conflicts to declare.
Références
J Control Release. 2001 Jun 15;73(2-3):121-36
pubmed: 11516493
Chem Soc Rev. 2017 Jun 6;46(11):3386-3401
pubmed: 28451673
ACS Appl Mater Interfaces. 2018 May 30;10(21):18161-18169
pubmed: 29553703
J Am Chem Soc. 2017 May 17;139(19):6530-6533
pubmed: 28460166
Nat Rev Drug Discov. 2010 Apr;9(4):308-24
pubmed: 20357803
J Am Chem Soc. 2019 Feb 13;141(6):2348-2355
pubmed: 30636404
Blood. 2002 Nov 15;100(10):3484-8
pubmed: 12393647
J Hepatol. 2002 Oct;37(4):463-70
pubmed: 12217599
Drug Des Devel Ther. 2012;6:125-32
pubmed: 22745531
Langmuir. 2016 Feb 9;32(5):1195-200
pubmed: 26794474
J Am Chem Soc. 2018 Aug 8;140(31):9912-9920
pubmed: 30008215
Biomatter. 2011 Jul-Sep;1(1):57-65
pubmed: 23507727
Proc Natl Acad Sci U S A. 2006 Jul 5;103(27):10186-10191
pubmed: 16798880
Arch Otolaryngol Head Neck Surg. 1990 Jul;116(7):779-85
pubmed: 2363913
J Mater Chem B. 2019 Oct 16;7(40):6099-6108
pubmed: 31549695
Adv Mater. 2017 Jan;29(4):
pubmed: 27885722
J Am Chem Soc. 2011 Aug 10;133(31):11920-3
pubmed: 21749096
Nano Lett. 2014 Oct 8;14(10):5761-5
pubmed: 25211437
Drug Discov Today. 2010 Dec;15(23-24):1058-69
pubmed: 20974281
Adv Healthc Mater. 2018 Nov;7(22):e1800950
pubmed: 30369102
ACS Nano. 2018 Aug 28;12(8):7538-7545
pubmed: 29969227
Adv Sci (Weinh). 2018 Nov 20;6(1):1801526
pubmed: 30643728
Pharmaceuticals (Basel). 2016 Jun 29;9(3):
pubmed: 27367704
PLoS One. 2018 Sep 25;13(9):e0204709
pubmed: 30252910
Phys Chem Chem Phys. 2014 Jun 7;16(21):9940-9
pubmed: 24445495
Nat Commun. 2015 Jun 04;6:7240
pubmed: 26041070
Nat Rev Drug Discov. 2011 Jul 01;10(7):521-35
pubmed: 21720407
ACS Biomater Sci Eng. 2019 Dec 9;5(12):6617-6631
pubmed: 33423481
Biologicals. 2013 Nov;41(6):415-23
pubmed: 24095600
Inorg Chem. 2015 Feb 16;54(4):1816-21
pubmed: 25650775
Chemistry. 2012 Jan 9;18(2):428-32
pubmed: 22161774
Nature. 2003 Jun 12;423(6941):705-14
pubmed: 12802325
Science. 2013 Aug 30;341(6149):1230444
pubmed: 23990564
J Pharm Sci. 2011 Feb;100(2):441-50
pubmed: 20653053
Inorg Chem. 2018 Dec 3;57(23):14480-14483
pubmed: 30444363
Adv Mater. 2011 Mar 11;23(10):1268-71
pubmed: 21381128
Open Glycosci. 2008 Jan 1;1:31-39
pubmed: 20640171
ACS Cent Sci. 2018 Nov 28;4(11):1457-1464
pubmed: 30555897
Acc Chem Res. 2017 Jun 20;50(6):1423-1432
pubmed: 28489346
Chem Sci. 2018 Mar 9;9(18):4217-4223
pubmed: 29780551
Adv Healthc Mater. 2018 Mar;7(6):e1701042
pubmed: 29210510
Adv Mater. 2019 Jan;31(2):e1805148
pubmed: 30480344
Biochim Biophys Acta. 2015 Feb;1853(2):299-307
pubmed: 25461841
ACS Nano. 2018 Jan 23;12(1):13-23
pubmed: 29309146
PLoS One. 2011 Feb 09;6(2):e16658
pubmed: 21347371
ACS Appl Mater Interfaces. 2017 Aug 16;9(32):27332-27337
pubmed: 28745483
ACS Appl Mater Interfaces. 2019 Mar 13;11(10):9740-9746
pubmed: 30776885
Sci Rep. 2015 May 27;5:10556
pubmed: 26014755
Chem Biol Drug Des. 2008 Dec;72(6):455-82
pubmed: 19090915
Pharmaceuticals (Basel). 2018 Feb 27;11(1):
pubmed: 29495527
Adv Mater. 2018 Sep;30(37):e1707365
pubmed: 29876985
Chem Sci. 2017 May 1;8(5):3939-3948
pubmed: 28553536
Angew Chem Int Ed Engl. 2015 Jun 15;54(25):7234-54
pubmed: 26036179
Sci Rep. 2019 Mar 20;9(1):4905
pubmed: 30894640
J Am Chem Soc. 2017 Jun 14;139(23):7952-7957
pubmed: 28520416
Chem Rev. 2012 Feb 8;112(2):1001-33
pubmed: 21939178
Anal Biochem. 1991 Aug 15;197(1):157-62
pubmed: 1952059
Glycobiology. 2017 Jan;27(1):3-49
pubmed: 27558841